NeoGenomics, Inc. (NASDAQ:NEO) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET

Company Participants

Lynn Tetrault - Executive Chair & Principal Executive Officer

William Bonello - Chief Financial Officer

Doug Brown - Chief Strategy and Corporate Development Officer

Charlie Eidson - Director, Investor Relations

Shashi Kulkarni - Chief Scientific Officer

David Sholehvar - Clinical Division President

Conference Call Participants

Brian Weinstein - William Blair

Matt Sykes - Goldman Sachs

Andrew Cooper - Raymond James

Alex Nowak - Craig Hallum Capital

Mark Massaro - BTIG

Puneet Souda - SVB Securities

Dan Brennan - Cowen

Operator

Good morning ladies and gentlemen. Thank you for standing by. Welcome to the NeoGenomics First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the managements prepared remarks there will be a question and answer session.

I would now like to turn the call over to the host, Executive Chair of NeoGenomics, Lynn Tetrault. Please go ahead.

Lynn Tetrault

Thank you, Kelly, and good morning. I'd like to welcome you to NeoGenomics first quarter 2022 conference call. Joining me to this call from our Fort Myers headquarters are Bill Bonello, our Chief Financial Officer, Doug Brown, our Chief Strategy and Corporate Development Officer, and Charlie Eidson, our Director of Investor Relations. Joining on the call via phone is Dr. Shashi Kulkarni, our Chief Scientific Officer and Executive Vice President of Research and Development.

Before we begin our prepared remarks, Charlie will discuss the forward-looking statements and the non-GAAP measures used on this call.

Charlie Eidson

This conference call includes forward looking statements about our 2022 initiatives, 2022 financial outlook, growth opportunities and anticipated operating results and performance. Each forward looking statements is subject to risks and uncertainties that could cause actual results to differ materially from those projected in such statements.

Additional information regarding these risk factors appears under the heading forward looking statements in the press release we issued this morning and in the risk factors section of our annual report on Form 10-K for the year ended December 31, 2021, that is filed with the Securities and Exchange Commission.

The forward looking statements made during this call speak only as of the original date of the call, and we undertake no obligation to update or revise any of these statements. In addition, during this conference call in order to provide greater transparency regarding our operating performance, we refer to certain non GAAP financial measures that involve adjustments to GAAP results.